Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

CIGB

Havana, Oct 4 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) on Sunday highlighted that new Jusvinza drug is Cuba's first therapeutic product based on synthetic peptide, so its production is expected to ramp up.
Havana, Aug 12 (Prensa Latina) Cuba´s Center for State Control of medicines, Equipment and Medical Devices (CECMED) on Wednesday authorized the start of a phase-II clinical trial with the vaccine candidate CIGB2020, seeking to stimulate the immune response against acute respiratory infections.